| 000 | 01718 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518085228.0 | ||
| 264 | 0 | _c20210409 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1360-0443 | ||
| 024 | 7 |
_a10.1111/add.14951 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarney, Greg | |
| 245 | 0 | 0 |
_aCardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study. _h[electronic resource] |
| 260 |
_bAddiction (Abingdon, England) _c08 2020 |
||
| 300 |
_a1534-1546 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBupropion _xadverse effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMental Disorders _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNicotinic Agonists _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSmoking Cessation _xmethods |
| 650 | 0 | 4 |
_aSmoking Cessation Agents _xadverse effects |
| 650 | 0 | 4 |
_aTobacco Use Cessation Devices _xadverse effects |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xdrug therapy |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aVarenicline _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBassett, Ken | |
| 700 | 1 | _aMaclure, Malcolm | |
| 700 | 1 | _aTaylor, Suzanne | |
| 700 | 1 | _aDormuth, Colin R | |
| 773 | 0 |
_tAddiction (Abingdon, England) _gvol. 115 _gno. 8 _gp. 1534-1546 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/add.14951 _zAvailable from publisher's website |
| 999 |
_c30653324 _d30653324 |
||